Идиопатическая гиперкальциурия у детей
Аннотация
В обзоре рассматриваются особенности проявлений идиопатической гиперкальциурии в детском возрасте. Обсуждаются различные методы лечения идиопатической гиперкальциурии у детей.
Об авторах
Н. М. Михеева
Алтайский государственный медицинский университет
Россия
Россия
Я. Ф. Зверев
Алтайский государственный медицинский университет
Россия
Россия
Г. И. Выходцева
Алтайский государственный медицинский университет
Россия
Россия
Список литературы
1. Kaneko K., Tsuchiya K., Kawamura R., et al. Low prevalence of hypercalciuria in Japanese children. Nephron 2002; 91: 439-443
2. Melian J.S., Garci'a-Nieto V., Sosa A.M. Herenci'a y prevalencia de hipercalciuria en la poblacion infantile de la isla de La Gomera. Nefrologia 2000; 20: 510-516
3. Kaneko K., Chiba M., Hashizume M. et al. Extremely high prevalence of hypercalciuria in children living in the Aral Sea region. Acta Paediatr 2002; 91: 1116-1120
4. Ларина Т.А., Кузнецова Т.А., Цыгин А.Н. Распространенность гиперкальциурии по результатам скринингового обследования детей региона с высокой частотой мочекаменной болезни. Российский педиатрический журнал 2007; 3: 41-44
5. Moore E.S., Coe F.L., McMann B.J., Favus M.J. Idiopathic hypercalciuria in children: prevalence and metabolic characteristics. J Pediatr 1978; 92 (6): 906-910
6. Hernandez Marco R., Nunes Gomez F., Fons Moreno J. et al. Excrecio, magnesio, âcido ûrico y âcido oxalic em ninos normales. An Es Pediatr 1988; 29: 99-104
7. Sargent J.D., Stukel T.A., Kresel J. Normal values for random urinary calcium to creatinine ratios in infancy. J Pediatr 1993; 123: 393-397
8. Manz F., Kehrt R., Lausen B., Merkel A. Urinary calcium excretion in healthy children and adolescents. Pediatr Nephrol 1999; 13: 894-849
9. Emamghorashi F., Davami M.H., Rohi R. Hypercalciuria in Jahrom’s school-age children: what is normal calcium-creatinine ratio? Iran J Kidney Dis 2010; 4 (2): 112-115
10. De Santo N.G., DiIorio B., Capasso G. et al. Population based data on urinary excretion of calcium, magnesium, oxalate, phosphate and uric acid in children from Cimitile (southern Italy). Pediatr Nephrol 1992; 6: 149-157
11. Fallahzadeh M.K., Fallahzadeh M.H., Mowla A., Derakhshan A. Hypercalciuria in children with urinary tract symptoms. Saudi J Kidney Dis Transpl 2010; 21 (4): 673-677
12. Heiliczer J.D., Canonigo B.B., Bishof N.A., Moore E.S. Noncalculi urinary tract disorders secondary to idiopathic hypercalciuria in children. Pediatr Clin North Am 1987; 34 (3): 711-718
13. Vachvanichsanong P., Malagon M., Moore E.S. Urinary incontinence due to idiopathic hypercalciuria in children. J Urol 1994; 152 (4): 1226-1228
14. Михеева Н.М., Выходцева Г.И., Зверев Я.Ф., Лобанов Ю.Ф. Клинико-лабораторные проявления идиопатической гиперкальциурии у детей. Фундаментальные исследования 2013; 7-2: 350-352
15. Penido M.G.M.G., Diniz J.S.S., Moreira M.L.S.F. et al. Idiopathic hypercalciuria: presentation of 471 cases. J Pediatr (Rio J) 2001; 77 (2): 101-104
16. Srivastava T., Schwaderer A. Diagnosis and management of hypercalciuria in children. Curr Opin Pediatr 2009; 21 (2): 214-219
17. Akl K., Ghawanmeh R. The clinical spectrum of idiopathic hyperuricosuria in children: isolated and associated with hypercalciuria/hyperoxaluria. Saudi J Dis Transpl 2012; 23 (5): 979-984
18. Aggarwal V.K., Jones K.V. Diffuse nephrocalcinosis and idiopathic renal hypercalciuria. Arch Dis Child 1989; 64 (7): 1055-1057
19. Freundlich M., Alonzo E., Bellorini-Font E., Weisinger J.R. Reduced bone mass in children with idiopathic hypercalciuria and in their asymptomatic mothers. Nephrol Dial Transplant 2002; 17 (8): 1396-1401
20. Copelovitch L. Urolithiasis in children. Pediatr Clin North Am 2012; 59 (4): 881-896
21. Kalia A., Travis L.B., Brouhard B.H. The association of idiopathic hypercalciuria and asymptomatic gross hematuria in children. J Pediatr 1981; 99: 716-719
22. Roy 3rd S., Stapleton F.B., Noe H.N., Jerkins G. Hematuria preceding renal calculus formation in children with hypercalciuria. J Pediatr 1981; 99: 712-715
23. Noe H.N., Stapleton F.B., Jerkins G., Roy S3rd. Clinical experience with pediatric urolithiasis. J Urol 1983; 129: 1166-1168
24. Stapleton F.B., Roy 3rd S., Noe H.N., Jerkins G. Hypercalciuria in children with hematuria. N Engl J Med 1984; 310 (21): 1345-1348
25. Wood E.G. Asymptomatic hematuria in childhood: a practical approach to evaluation. Indian J Pediatr 1999; 66 (2): 207-214
26. Srivastava R.N. Asymptomatic haematuria in children. J Indian Med Assoc 2002; 100 (2): 88-92
27. Stapleton F.B. Idiopathic hypercalciuria: association with isolated hematuria and risk for urolithiasis in children. The Southwest Pediatric Nephrology Study Group. Kidney Int 1990; 37 (2): 807-811
28. Parekh D.J., Pope J.C. 4th, Adams M.C., Brock J.W. 3rd. The association of an increased urinary calcium-to-creatinine ratio, and asymptomatic gross and microscopic hematuria in children. J Urol 2002; 167 (1): 272-274
29. La Manna A., Polito C., Cioce F. et al. Calyceal microlithiasis in children: report on 196 cases. Pediatr Nephrol 1998; 12: 214-217
30. Escribano J., Balaguer A., Martin R. et al. Childhood idiopathic hypercalciuria - clinical significance of renal calyceal microlithiasis and risk of calcium nephrolithiasis. Scand J Urol Nephrol 2004; 38: 422-426
31. Bergstein J., Leiser J., Andreoli S. The clinical significance of asymptomatic gross and microscopic hematuria in children. Arch Pediatr Adolesc Med 2005; 159: 353-355
32. Lau K.K. Clinical manifestations of pediatric idiopathic hypercalciuria. Front Biosci(Elite Ed) 2009; 1: 52-59
33. Alon U., Warady B.A., Hellerstein S. Hypercalciuria in the frequency-dysuria syndrome of childhood. J Pediatr 1990; 116 (1): 103-105
34. Parekh D.J., Pope J.C. 4th , Adams M.C., Brock J.W. 3rd. The role of hypercalciuria in a subgroup of dysfunctional voiding syndromes of childhood. J Urol 2000; 164 (3, Pt. 2): 1008-1010
35. Nikibakhsh A., Poostindooz H., Mahmoodzadeh H. et al. Is there any correlation between hypercalciuria and nocturnal enuresis? Indian J Nephrol 2012; 22 (2): 88-93
36. Aceto G., Penza R., Coccioli M.S. et al. Enuresis subtypes based on nocturnal hypercalciuria: A Multicenter Study. J Urol 2003; 170 (4, Pt. 2): 1670-1673
37. Mohammadjafari H., Kosaryan M., Karami H., Dabaghzadeh A. Response of enuretic children with and without hypercalciuria to nasal desmopressin. Iran J Pediatr 2009; 19: 5-10
38. Scwaderer A., Srivastava T. Complications of hypercalciuria. Front Biosci (Elite Ed) 2009; 1: 306-315
39. Valenti G., Laera A., Pace G. et al. Urinary aquaporin 2 and calciuria correlate with the severity of enuresis in children. J Am Soc Nephrol 2000; 11 (10): 1873-1881
40. Aceto G., Penza R., Delvecchio M. et al. Sodium fraction excretion rate in nocturnal enuresis correlates with nocturnal polyuria and osmolality. J Urol 2004; 171: 2567-2570
41. Valenti G., Laera A., Gouraud S. et al. Low-calcium diet in hypercalciuric enuretic children restores AQP2 excretion and improves clinical symptoms. Am J Physiol Renal Physiol 2002; 283: F895-F903
42. Студеникин В.М. Проблема ночного энуреза у детей: обзор литературы (2012-2013). Лечащий врач 2013; 5: 50-53
43. Pace G., Aceto G., Cormio L. et al. Nocturnal enuresis can be caused by absorptive hypercalciuria. Scand J Urol Nephrol 1999; 33 (2): 111-114
44. Raes A., Dehoorne J., Hoebeke P. et al. Abnormal circadian rhythm of dieresis or nocturnal polyuria in a subgroup of children with enuresis and hypercalciuria is related to increased sodium retention during daytime. J Urol 2006; 176 (3): 1147-1151
45. Azhir A., Nasseri F., Fazel A. et al. theology of enuresis among primary school children in Isfahan, Iran. Saudi Med J 2007; 28: 1706-1710
46. Raes A., Dossche L., Hertegonne N. et al. Hypercalciuria is related to osmolar excretion in children with nocturnal enuresis. J Urol 2010; 183: 297-301
47. Marrero Pérez C.L., Garcfa Nieto V., Luis Yanes M.I. Study of renal morphology and function in children with nocturnal enuresis. Relationship with sensitivity or resistance to desmopressin. An Pediatr(Barc) 2005; 63 (6): 475-479
48. Neveus T., Hansell P., Stenberg A. Vasopressin and hypercalciuria in enuresis: a reappraisal. BJU Int 2002; 90 (7): 725-729
49. Kamperis K., Hagstroem S., Rittig S. et al. Urinary calcium excretion in healthy children and children with primary monosymp-tomatic nocturnal enuresis. J Urol 2006; 176 (2): 770-773
50. Apley J., Naish N. Recurrent abdominal pain: a field survey of 1000 school children. Arch Dis Child 1958; 33 (168): 165-170
51. Subcommittee on chronic abdominal pain. Chronic abdominal pain in children. AAP news 2005; 115 (3): 812-815
52. Oberlander T.F., Rappaport L.A. Recurrent abdominal pain during childhood. Pediatr Rev 1993; 14: 313-319
53. Pearl R.H., Irish M.S., Caty M.G. et al. The approach to common abdominal diagnoses in infants and children: part II. Pediatr Clin North Am 1998; 45 (6): 1287-1326
54. Chitkara D.K., Rawat D.J., Talley N.Y. The epidemiology of childhood recurrent abdominal pain in Western countries: a systematic review. Am J Gastroenterol 2005; 100 (8): 1868-1875
55. Dursun I., Poyrazoglu H.M., Dusunsel R. et al. Pediatric urolithiasis: an 8-year experience of single centre. Int Urol Nephrol 2008; 40 (1): 3-9
56. Vachvanichsanong P., Malagon M., Moore E.S. Recurrent abdominal and flank pain in children with idiopathic hypercalciuria. Acta Paediatr 2001; 90 (6): 643-648
57. Polito C., Cioce F., Signoriello G., La Manna A. Central/ diffuse abdominal perception of urological pain in children. Acta Paediatr 2006; 95 (1): 82-85
58. Polito C., La Manna A., Signoriello G., Marte A. Recurrent abdominal pain in childhood urolithiasis. Pediatrics 2009; 124 (6): e1088-e1094
59. Coe F.L., Parks J.H., Asplin J.R. The pathogenesis and treatment of kidney stones. N Engl J Med 1992; 327: 1141-1152
60. Curhan G.C., Willett W.C., Rimm E.B., Stampfer M.J. Family history and risk of kidney stones. J Am Soc Nephrol 1997; 8 (10): 1568-1573
61. Polito C., La Manna A., Nappi B. et al. Idiopathic hypercalciuria and hyperuricosuria: family prevalence of nephrolithiasis. Pediatr Nephrol 2000; 14 (12): 1102-1104
62. Polito C., Marte A., La Manna A. Appendectomy in children with hypercalciuria/hyperuricosuria. J Pediatr Urol 2005; 1 (4): 279-282
63. Yousefi P., Cyrus A., Dorreh F. et al. Effect of hydrochlorothiazide on reducing recurrent abdominal pain in girls with idiopathic hypercalciuria. J Res Med Sci 2011; 16 [Suppl 1]: S433-S436
64. López M.M., Castillo L.A., Chavez J.B., Ramones C. Hypercalciuria and recurrent urinary tract infection in Venezuelen children. Pediatr Nephrol 1999; 13 (5): 433-437
65. Vachvanichsanong P., Malagon M., Moore E.S. Urinary tract infection in children associated with idiopathic hypercalciuria. Scand J Urol Nephrol 2001; 35 (2): 112-116
66. Biyikli N.K., Aplay H., Guran T. Hypercalciuria and recurrent urinary tract infections: incidence and symptoms in children over 5 years of age. Pediatr Nephrol 2005; 20 (10): 1435-1438
67. Stojanović V.D., Milošević B.O., Djapić M.B., Bubalo J.D. Idiopathic hypercalciuria associated with urinary tract infection in children. Pediatr Nephrol 2007; 22 (9): 1291-1295
68. Sadeghi-Bojd S., Hashemi M. Hypercalciuria and recurrent urinary tract infections among children in Zahedan, Iran. J Pak Med Assoc 2008; 58 (11): 624-626
69. Nacaroglu H.T., Demircin G., Bülbül M. et al. The association between urinary tract infection and idiopathic hypercalciuria in children. Ren Fail 2013; 35 (3): 327-332
70. Tabel X., Mir S. The long-term outcomes of idiopathic hypercalciuria in children. J Pediatr Urol 2006; 2: 453-458
71. Laufer J., Boichis H. Urolithiasis in children: current medical management. Pediatr Nephrol 1989; 3 (3): 317-321
72. Milliner D.S., Murphy M.E. Urolithiasis in pediatric patients. Mayo Clin Proc 1993; 68 (3): 241-248
73. Mannhardt W., Becker A., Putzer M. Host defense within the urinary tract. I. Bacterial adhesion initiates an uroepithelial defense mechanism. Pediatr Nephrol 1996; 10: 568-572
74. Mannhardt W., Putzer M., Schulte-Wissermann H. Host defense within the urinary tract. II. Signal transducing events activate the uroepithelial defense. Pediatr Nephrol 1996; 10: 573-577
75. Жариков А.Ю., Зверев Я.Ф., Брюханов В.М., Лампатов В.В. Современные представления о модуляторах оксалатного нефролитиаза. I. Стимуляторы кристаллизации. Нефрология 2009; 13 (1): 56-72
76. Зверев Я.Ф., Жариков А.Ю., Брюханов В.М., Лампатов В.В. Модуляторы оксалатного нефролитиаза. Ингибиторы кристаллизации. Нефрология 2010; 14 (1): 29-49
77. Lieske J.C., Hammes M., Hoyer J.R., Toback F.G. Renal cell osteopontin production is stimulated by calcium oxalate monohydrate crystals. Kidney Int 1997; 51: 679-686
78. Akil I., Kavukcu S., Inan S. et al. Evaluation of histologic changes in the urinary tract of hypercalciuric rats. Pediatr Nephrol 2006; 21 (11): 1681-1689
79. Arant BS Jr. Vesicoureteral reflux and renal injury. Am J Kidney Dis 1991; 17: 491-511
80. Garcia-Nieto V., Siverio B., Monge M. et al. Urinary calcium excretion in children with vesicoureteral reflux. Nephrol Dial Transplant 2003; 18 (3): 507-511
81. Garcia-Nieto V., Navarro J.F., Luis-Yanes M.I. et al. Hypercalciuria in pediatric patients with uretero-pelvic junction obstruction is of genetic origin. Scand J Urol Nephrol 2007; 41 (2): 144-148
82. Mahmoodzadeh H., Nikibakhsh A., Karamyyar M. et al. Idiopathic hypercalciuria in children with vesico ureteral reflux and recurrent urinary tract infection. Urol J 2010; 7 (2): 95-98
83. VanDervoort K., Wiesen J., Frank R. et al. Urolithiasis in pediatric patients: a single center study of incidence, clinical presentation and outcome. J Urol 2007; 177 (6): 2300-2305
84. Aplay H., Ozen A., Gokce I., Biyikli N. Clinical and metabolic features of urolithiasis and microlithiasis in children. Pediatr Nephrol 2009; 24 (11): 2203-2209
85. Зверев Я.Ф., Брюханов В.М., Лампатов В.В., Жариков А.Ю. Современные представления о роли физико-химических факторов в патогенезе кальциевого нефролитиаза. Нефрология 2009; 13 (1): 39-50
86. Spivacow F.R., Negri A.L., del Valle E.E. et al. Metabolic risk factors in children with kidney stone disease. Pediatr Nephrol 2008; 23: 1129-1133
87. Lieberman E. Importance of metabolic contributions to urolithiasis in pediatric patients. Mayo Clin Proc 1993; 68: 313-315
88. Alon U.S., Zimmerman H., Alon M. Evaluation and treatment of pediatric idiopathic urolithiasis - revisited. Pediatr Nephrol 2004; 19 (5): 516-520
89. Basaklar A.C., Kale N. Experience with childhood urolithiasis. Report of 196 cases. Br J Urol 1991; 67: 203-205
90. Özokutan B.H., Küçükaydin M., Gündüz Z. et al. Urolithiasis in childhood. Pediatr Surg Int 2000; 16 (1-2): 60-63
91. Acar B., Inci Arikan F., Emeksiz S., Dallar Y. Risk factors for nephrolithiasis in children. World J Urol 2008; 26: 627-630
92. Tabel Y., Akin I.M., Tekin S. Clinical and demographic characteristics of children with urolithiasis. Single-centre experience from eastern Turkey. Urol Int 2009; 83: 217-221
93. Coward R.L., Peters C.J., Duffy P.G. Epidemiology of paediatric renal stone disease in the UK. Arch Dis Child 2003; 88 (11): 962-965
94. Cameron M.A., Sakhaee K., Orson W.M. Nephrolithiasis in children. Pediatr Nephrol 2005; 20: 1587-1592
95. Clayton D.B., Pope J.C. 4th. The increased pediatric stone disease problem. Ther Adv Urol 2011; 3 (1): 3-12
96. Alon U.S., Berenbom A. Idiopathic hypercalciuria of childhood: 4 - to 11-year outcome. Pediatr Nephrol 2000; 14 (10-11): 1011-1015
97. Garcia C.D., Miller L.A., Stapleton F.B. Natural history of hematuria associated with hypercalciuria in children. Am J Dis Child 1991; 145 (10): 1204-1207
98. Polito C., La Manna A., Cioce F. et al. Clinical presentation and natural course of idiopathic hypercalciuria in children. Pediatr Nephrol 2000; 15 (3-4): 211-214
99. Churchill D.N., Maloney C.M., Nolan R. et al. Pediatric urolithiasis in the 1970s. J Urol 1980; 123: 237-238
100. Lerolle N., Lantz B., Paillard F. et al. Risk factors for nephrolithiasis in patients with familial idiopathic hypercalciuria. Am J Med 2002; 113 (2): 99-103
101. Щеплягина Л.А., Моисеева Т.Ю. Проблемы остеопо-роза в педиатрии: возможности профилактики. Российский медицинский журнал 2003; 11 (27): 1554-1556
102. Saggese G., Baroncelli G.I., Bertelloni S. Osteoporosis in children and adolescents: diagnosis, risk factors, and prevention. J Pediatr Endocrinol Metab 2001; 14 (7): 833-859
103. Steelman J., Zeitler P. Osteoporosis in pediatrics. Pediatr Rev 2001; 22 (2): 56-65
104. Penido M.G.M.G., Tavares M.D., Linhares M.C. et al. Longitudinal study of bone mineral density in children with idiopathic hypercalciuria. Pediatr Nephrol 2012; 27: 123-130
105. Carrascosa A., Gussynie M., Yeste D. et al. Bone mass acquisition during infancy, childhood and adolescence. Acta Paediatr 1995; 411: 18-23
106. Baroncelli G.I., Bertelloni S., Sodini F., Saggese G. Osteoporosis in children and adolescents: etiology and management. Paediatr Drugs 2005; 7: 295-323
107. Loro M.L., Sayre J., Roe T.F. et al. Early identification of children predisposed to low peak bone mass and osteoporosis later in life. J Clin Endocrinol Metab 2000; 85: 3908-3918
108. Schalamon J., Singer G., Schwantzer G., Nietosvaara Y. Quantitative ultrasound assessment in children with fractures. J Bone Miner Res 2004; 19: 1276-1279
109. Clark E.M., Tobias J.H., Ness A.R. Association between bone density and fractures in children: a systematic review and metaanalysis. Pediatrics 2006; 117: 291-297
110. Perrone H.C., Lewin S., Langman C.B. et al. Bone effects of the treatment of children with absorptive hypercalciuria. Pediatr Nephrol 1992; 6: 115
111. Perrone H.C., Marone M.M.S., Bianco A.C. et al. Bone mineral density in hypercalciuric children: a 5 year follow-up. Pediatr Nephrol 1995; 9: 121
112. Garcia-Nieto V., Ferrandez C., Monge M. et al. Bone mineral density in pediatric patients with idiopathic hypercalciuria. Pediatr Nephrol 1997; 11 (5): 578-583
113. Garcia Nieto V., Navarro J.F., Ferrandez C. Bone loss in children with idiopathic hypercalciuria. Nephron 1998; 78: 341-342
114. Penido M.G., Lima E.M., Marino V.S. et al. Bone alterations in children with idiopathic hypercalciuria at the time of diagnosis. Pediatr Nephrol 2003; 18 (2): 133-139
115. Щеплягина Л.А., Моисеева Т.Ю., Круглова И.В. Снижение минеральной плотности костей у детей: взгляд педиатра. Лечащий врач 2002; 9: 26-30
116. Kanis J.A., Melton J.J. 3th, Christiansen C. et al. The diagnosis of osteoporosis. J Bone Miner Res 1994; 9: 1137-1141
117. Garcia-Nieto V., Navarro J.F., Monge M., Garcia-Rodriguez V.E. Bone mineral density in girls and their mothers with idiopathic hypercalciuria. Nephron Clin Pract 2003; 94: 89-93
118. Schwaderer A.L., Cronin R., Bates C.M., Mahan J.D. Increased incidence of osteoporosis in children with hypercalciuria and/or nephrolithiasis. Pediatric Academic Societies 2007 E-PAS2007: 615874.1 (abstract)
119. Skalova S., Palicka V., Kutilek S. Bone mineral density and urinary N-acetyl-beta-D-glucosaminidase activity in paediatric patients with idiopathic hypercalciuria. Nephrology 2005; 10: 99-102
120. Zerwekh J.E. Bone disease and hypercalciuria in children. Pediatr Nephrol 2010; 25: 395-401
121. Lau K.K., Butani L. Treatment strategies for pediatric idiopathic hypercalciuria. Front Biosci (Elite Ed) 2009; 1: 299-305
122. Rodriguez L.M., Santos F., Mâlaga S. et al. Follow-up of children with idiopathic hypercalciuria. Pediatr Nephrol 1992; 6: 114
123. Curhan G., Willett W., Rimm E., Stampfer M. A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones. N Engl J Med 1993; 328: 833-838
124. Borghi L., Meschi T., Amato F. et al. Urinary volume, water recurrences in idiopathic calcium nephrolithiasis: a 5 year randomized prospective study. J Urol 1996; 11: 839-884
125. Curhan G.C., Willett W.C., Speizer F.E. et al. Comparison of dietary calcium with supplemental calcium and other nutrients as factors affecting the risk for kidney stones in women. Ann Intern Med 1997; 11: 497-504
126. Curhan G., Willett W., Knight E., Stampfer M. Dietary factors and the risk of incident kidney stones in younger women: Nurses’ Health Study II. Arch Intern Med 2004; 164: 885-891
127. Брюханов В.М., Зверев Я.Ф., Лампатов В.В. и др. Влияние питьевых режимов на движущие силы кристаллизации при экспериментальном нефролитиазе. Урология 2011; (1): 6-11
128. Taylor E., Curhan G. Diet and fluid prescription in stone disease. Kidney Int 2006; 70: 835-839
129. Taylor E.N., Stampfer M.J., Curhan G.C. Dietary factors and the risk of incident kidney stones in men: new insights after 14 years of follow-up. J Am Soc Nephrol 2004; 11: 3225-3232
130. Kairaitis L. The CARI guidelines. Kidney stones: prevention of recurrent calcium nephrolithiasis. Caring for Australians with renal impairment (CARI). Nephrology (Carlton) 2007; 11 [Suppl 1]: S11-S20
131. Lopez M., Hoppe B. History, epidemiology and regional diversities of urolithiasis. Pediatr Nephrol 2010; 11 (1): 49-59
132. Nicoletta J., Lande M. Medical evaluation and treatment of urolithiasis. Pediatr Clin North Am 2006; 53: 479-491
133. Liern M., Bohorquez M., Vallejo G. Treatment of idiopathic hypercalciuria and its impact on associated diseases. Arch Argent Pediatr 2013; 111 (2), pii: S0325-00752013000200005. Doi: 10.1590/S0325-00752013000200005
134. Nouvenne A., Meschi T., Guerra A. et al. Dietary treatment of nephrolithiasis. Clin cases Miner Bone Metab 2008; 11 (2): 135-141
135. Vezzoli G., Arcidiacono T., Puzzovio M., Mora S. Comparative study of the short-term effect of mineral water on calcium metabolism. G Ital Nefrol 2010; 27 (4): 391-395
136. Seltzer M., Low R., McDonald M. et al. Dietary manipulation with lemonade to treat hypocitraturic calcium nephrolithiasis. J Urol 1996; 156: 907-909
137. Itoh Y. Yasui T., Okada A. et al. Preventive effects of green tea on renal stone formation and the role of oxidative stress in nephrolithiasis. J Urol 2005; 173 (1): 271-275
138. Jeong B.C., Kim B.S., Kim J.I., Kim H.H. Effects of green tea on urinary stone formation: an in vivo and in vitro study. J Endourol 2006; 20 (5): 356-361
139. Odvina C. Comparative value of orange juice versus lemonade in reducing stone-forming risk. Clin J Am Soc Nephrol 2006; 1: 1269-1274
140. Meschi T., Nouvenne A., Borghi L. Lifestyle recommendations to reduce the risk of kidney stones. Urol Clin North Am 2011; 11 (3): 313-320
141. Dogliotti E., Vezzoli G., Nouvenne A. et al. Nutrition in calcium nephrolithiasis. J Transl Med 2013, 11: 109. Published online 2013 May 1. Doi: 10.1186/1479-5876-11-109
142. Shuster J., Jenkins A., Logan C. et al. Soft drink consumption and urinary stone recurrence: a randomized prevention trial. J Clin Epidemiol 1992; 45: 911-916
143. Curhan G.C., Willett W.C., Rimm E.B. et al. Prospective study of beverage use and the risk of kidney stones. Am J Epidemiol 1996; 11 (3): 240-247
144. Curhan G.C., Willett W.C., Speizer.FE., Stampfer M.J. Beverage use and risk for kidney stones in women. Ann Intern Med 1998; 128: 534-540
145. Rodgers A. Effect of cola consumption on urinary biochemical and physicochemical risk factors associated with calcium oxalate urolithiasis. Urol Res 1999; 11: 77-81
146. Fink H.H., Akornor J.W., Garimella P.S. Diet, fluid, or supplements for secondary prevention of nephrolithiasis: a systematic review and meta-analysis of randomized trials. Eur Urol 2009; 11: 72-80
147. Bataille P., Charransol G., Gregoire I. et al. Effect of calcium restriction on renal excretion of oxalate and the probability of stones in the various pathophysiological groups with calcium stones. J Urol 1983; 130: 218-223
148. Bataille P., Pruna A., Gregoire I. et al. Critical role of oxalate restriction in association with calcium restriction to decrease the probability of being a stone former: insufficient effect in idiopathic hypercalciuria. Nephron 1985; 39: 321-324
149. Lemann J. Jr, Adams N.D., Gray R.W. Urinary calcium excretion in human beings. N Engl J. Med 1979; 11: 535-541
150. Nielsen S.J., Popkin B.M. Changes in beverage intake between 1977 and 2001. Am J. Prev Med 2004; 27: 205-210
151. Bush N.C., Xu L., Brown B.J. et al. Hospitalizations for pediatric stone disease in United States, 2002-2007. J. Urol 2010; 183: 1151-1156
152. Daudon M. Epidemiology of nephrolithiasis in France. Ann Urol (Paris) 2005; 39 (6): 209-231
153. Lehmann J. Jr, Pleuss J.A., Gray R.W. Increased dietary calcium intakes reduce urinary oxalate excretion in healthy adults. In: Walzer V.R., Sutton R.A.L., Cameron E.C.B., Pak C.Y.C., RobertsonWG., eds. Urolithiasis. Plenum Press, NewYork, London, 1989; 435-438
154. Jaeger P., Robertson W.G. Role of dietary intake and intestinal absorption of oxalate in calcium stone formation. Nephron Physiol 2004; 98: 64-71
155. Srivastava T., Alon U.S. Pathophysiology of hypercalciuria in children. Pediatr Nephrol 2007; 22: 1659-1673
156. Wroblewski T., Wystrychowski A. Hypercalciuria. Przegl Lek 2011; 68 (2): 107-113
157. Borghi L., Schianchi T., Meschi T. et al. Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria. N Engl J. Med 2002; 346 (11): 77-84
158. Périmenis P., Wémeau J.L., Vantyghem M.C. Hypercalciuria. Ann Endocrinol (Paris) 2005; 66 (6): 532-539
159. US Institute of Medicine. Strategies to Reduce Sodium Intake in the United States. National Academy of Sciences 2010, http://www.iom.edu/Reports/2010/
160. Brown I.J., Tzoulaki I., Candeias V., Elliott P. Salt intakes around the world: implications for public health. Int J. Epidemiol 2009; 183: 1151-1156
161. Gunn J.P., Kuklina E.V., Keenan N.L., Labarthe D.R. Sodium intake among adults - United States, 2005-2006. Morbidity Mortality Weekly 2010; 59. http://www.cdc.gov/mmwr/preview/mmwrhtml/
162. Lemann J.Jr. Pathogenesis of idiopathic hypercalciuria and nephrolithiasis. In: Coe F.L., Favus M.J., eds. Disorders of bone and mineral metabolism. Raven Press, New York, 1992; 685-706
163. Nordin B.E.C., Need A.G., Morris H.A., Horowitz M. The nature and significance of the rela 1622
164. Sakhaee K., Harvey J.A., Padalino P.K. et al. The potential role of salt abuse on the risk for kidney stone formation. J. Urol 1993; 150: 310-312
165. Zhou B.F., Stamler J., Dennis B. et al. Nutrient intakes of middle-aged men and women in China, Japan, United Kingdom and United States in the late 1990s: the INTERMAP Study. J. Hum Hypertens 2003; 17: 623-630
166. Massey L.K., Whiting S.J. Dietary salt, urinary calcium and kidney stone risk. Nutr Rev 1995; 11: 131-134
167. Кучер А.Г., Каюков И.Г., Есаян А.М., Ермаков Ю.А. Лечебное питание при хронической почечной недостаточности. Рекомендации для больных. Эскулап, Санкт-Петербург, 1997; 20-37
168. Poujeol P., Chabardes D., Roined N., Rouffignac C.D. Influence of extracellular fluid volume expansion on magnesium, calcium and phosphate handling along the rat nephron. Pflugers Arch 1976; 365: 203-211
169. Colussi G., Surian M., De Ferrari M.E. et al. Relationship between sodium intake, proximal tubular function and calcium excretion in normal subjects and idiopathic hypercalciuria. Eur Proc Eur Dial Transplant Assoc 1983; 11: 455-459
170. Bourdeau J.E., Attie M.F. Calcium metabolism. In: Narins NG., ed. Maxwell and Kleeman's clinical disorders of fluid and electrolyte metabolism, 5th ed. McGraw-Hill Inc. Health Professions Division, New York, 1994; 243-306
171. Frassetto L.A., Morris J.R.C., Sebastian A. Dietary sodium chloride intake independently predicts the degree of hyperchlore-mic metabolic acidosis in healthy humans consuming a net acid-producing diet. Am J. Physiol Renal Physiol 2007; 293: F521-F525
172. Phillips M., Cooke J.N. Relation between urinary calcium and sodium in patients with idiopathic hypercalciuria. Lancet 1967; 1 (7504): 1354-1357
173. Muldowney F.P., Freaney R., Moloney M.F. Importance of dietary sodium in the hypercalciuria syndrome. Kidney Int 1982; 22: 292-296
174. Silver J., Friedlaender M., Rubinger D., Popovtzer M. Sodium-dependent idiopathic hypercalciuria in renal-stone formers. Lancet 1983; 2 (8348): 484-486
175. Burtis W.J., Gay L., Insogna K.L. et al. Dietary hypercalciuria in patients with calcium oxalate kidney stones. Am J. Clin Nutr 1994; 60: 424-429
176. Lin P.H., Ginty F., Appel L.J. et al. The DASH diet and sodium reduction improve markers of bone turnover and calcium metabolism in adults. J. Nutr 2003; 133: 3130-3136
177. Nouvenne A., Meschi T., Prati B. et al. Effect of a low-salt diet on idiopathic hypercalciuria in calcium-oxalate stone formers: a 3-mo randomized controlled trial. Am J. Clin Nutr 2010; 91 (3): 565-570
178. Stapleton B. Childhood stones. Endocrinol Metab Clin North Am 2002; 31: 1001-1015
179. Rodriguez-Soriano J., Ubetagoyena M., Vallo A. Renal potassium excretion is reduced in children with idiopathic hypercalciuria. Miner Electrolyte Metab 1991; 17: 357-361
180. Cirillo M., Laurenzi M., Panarelli W., Stamler J. Urinary sodium to potassium ratio and urinary stone disease. The Gubbio Population Study Research Group. Kidney Int 1994; 46: 1133-1139
181. Lemann J. Jr, Gray R. Idiopathic hypercalciuria. J. Urol 1989; 141: 715-718
182. Osorio A., Alon U. The relationship between urinary calcium, sodium, and potassium excretion and the role of potassium in treating idiopathic hypercalciuria. Pediatrics 1997; 100: 675-681
183. Lemann J. Jr. Relationship between urinary calcium and net acid excretion as determined by dietary protein and potassium: a review. Nephron 1999; 81: 18-25
184. Polito C., La Manna A., Maiello R. et al. Urinary sodium and potassium excretion in idiopathic hypercalciuria of children. Nephron 2002; 91 (1): 7-12
185. Okamoto N., Aruda S., Matsuzaki S. et al. Associations between renal sodium-citrate cotransporter (hNaDC-1) gene polymorphism and urinary citrate excretion in recurrent renal calcium stone formers and normal controls. Int J. Urol 2007; 11 (4): 344-349
186. Zuckerman J., Assimos D.G. Hypocitraturia: pathophysiology and medical management. Rev Urol 2009; 11 (3): 134-144
187. Allen L., Oddoye A., Margen S. Protein-induced hypercalciuria: a longer term study. Am J. Clin Nutr 1979; 32: 741-749
188. Giannini S., Nobile M., Sartori L. et al. Acute effects of moderate dietary protein restriction in patients with idiopathic hypercalciuria and calcium nephrolithiasis. Am J. Clin Nutr 1999; 69: 267-271
189. Wasserstein A.G., Stolley P.D., Soper K.A. et al. Case-control study of risk factors for idiopathic calcium nephrolithiasis. Miner Electrolyte Metab 1987; 13: 85-95
190. Bataille P., Fardellone P., Ghazali A. et al. Pathophysiology and treatment of idiopathic hypercalciuria. Curr Opin Rheumatol 1998; 10 (4): 373-388
191. Naseri M., Sadeghi R. Role of high-dose hydrochlorothiazide in idiopathic hypercalciuric urolithiasis of children. Iran J. Kidney Dis 2011; 5 (3): 162-168
192. Hofbauer J., Höbarth K., Szabo N., Marberger M. Alkali citrate prophylaxis in idiopathic recurrent calcium oxalate urolithiasis - a prospective randomized study. Br J. Urol 1994; 73: 362-365
193. Ettinger B., Pak C.Y., Citron J.T. et al. Potassium-magnesium citrate is an effective prophylaxis against recurrent calcium oxalate nephrolithiasis. J. Urol 1997; 158: 2069-2073
194. Weisinger J.R., Alonzo E., Machado C. et al. Role of bones in the physiopathology of idiopathic hypercalciuria: effect of amino-bisphosphinate alendronate. Medicina (B Aires) 1977; 57 [Suppl 1]: 45-48
195. Tekin A., Tekgul S., Atsu N. et al. Oral potassium citrate treatment for idiopathic hypocitraturia in children with calcium urolithiasis. J. Urol 2002; 168: 2572-2574
196. Sarica K., Erturhans S., Yurtseven C., Yagci F. Effect of potassium citrate therapy on stone recurrence and regrowth after extracorporeal shockwave lithotripsy in children. J. Endourol 2006; 20: 875-879
197. Pak C.Y.C., Peterson R.D., Poindexter J. Prevention of spinal bone loss by potassium citrate in cases of calcium urolithiasis. J. Urol 2002; 168 (1): 31-34
198. Sellmeyer D.E., Schloetter M., Sebastian A. Potassium citrate prevents increased urine calcium excretion and bone resorption induced by a hogh sodium chloride diet. J. Clin Endocrinol Metab 2002; 87: 2008-2012
199. Vescini F., Buffa A., La manna G. et al. Long-term potassium citrate therapy and bone mineral density in idiopathic calcium stone formers. J. Endocrinol Invest 2005; 28: 218-222
200. Dawson-Hughes B., Harris S.S., Palermo N.J. et al. Treatment with potassium bicarbonate lowers calcium excretion and bone resorption in older men and women. J. Clin Endocrinol Metab 2009; 94: 96-102
201. Zhou H., Choong P., McCarthy R. et al. In situ hybridization to show sequential expression of osteoblast gene markers during bone formation in vivo. J. Bone Miner Res 1994; 9: 1489-1499
202. Marangella M., Di Stefano M., Casalis S. et al. Effects of potassium citrate supplementation on bone metabolism. Calcif Tissue Int 2004; 74: 330-335
203. Auron A., Srivastava T., Blowey D.L. et al. Effects of low vs. high dose potassium citrate on urine chemistry and acid-base status. J. Am Soc Nephrol 2007; 18: 73A
204. Hymes L.C., Warshaw B.L. Thiazide diuretics for the treatment of children with idiopathic hypercalciuria and hematuria. J. Urol 1987; 138 (5): 1217-1219
205. Ohkawa M., Tokunaga S., Nakashima T. et al. Thiazide treatment for calcium urolithiasis in patients with idiopathic hy-percalciuria. Br J. Urol 1992; 69 (6): 571-576
206. Borghi L., Meschi T., Guerra A., Novarini A. Randomized prospective study of a nonthiazide diuretic, indapamide, in preventing calcium stone recurrence. J. Cardiovasc Pharmacol 1993; 22 [Suppl 6]: S78-S86
207. Reusz G.S., Dobos M., Tulassay T., Miltenyi M. Hydrochlorothiazide treatment of children with hypercalciuria: effects and side effects. Pediatr Nephrol 1993; 7 (6): 699-702
208. Audran M., Legrand E. Hypercalciuria. Joint Bone Spine 2000; 67 (6): 509-515
209. Raja K.A., Schurman S., D’Mello R.G. et al. Responsiveness of hypercalciuria to thiazide in Dent’s disease. J. Am Soc Nephrol 2002; 13: 2938-2944
210. Gillespie R.S., Stapleton F.B. Nephrolithiasis in children. Pediatr Rev 2004; 25 (4): 131-139
211. Escribano J., Balaguer A., Pagone F. et al. Pharmacological interventions for hypercalciuria. Cochrane Database Syst Rev 2009, 1: CD 004754. Doi: 10.1002/14651858. CD 004754. pub 2
212. Mensenkamp A., Hoenderop J., Bindels R. Recent advances in renal tubular calcium reabsorption. Curr Opin Nephrol Hypertens 2006; 15: 524-529
213. Costanzo L.S., Windhager E.E. Calcium and sodium transport by the distal convoluted tubule of the rat. Am J. Physiol 1978; 235: F492-F506
214. Jang H.R., Lee J.W., Heo N.J. et al. Effects of thiazide on the expression of transient receptor potential vanilloid 5 and calbindin-D28K in a hypercalciuria rat model. J. Am Soc Nephrol 2006; 17: 355A
215. Jang H.R., Kim S., Heo N.J. et al. Effects of thiazide on the expression of TRPV5, calbindin-D28K, and sodium transporters in hypercalciuric rats. J. Korean Med Sci 2009; 24 [Suppl]: S161-S169
216. Брюханов В.М., Зверев Я.Ф. Побочные эффекты современных диуретиков. Метаболические и токсико-аллергические аспекты. ЦЭРИС, Новосибирск, 2003; 115-172
217. Jiang Y., Ferguson W.B., Peng J.B. WNK4 enhances TRPV5-mediated calcium transport: potential role in hypercalciuria of familial hyperkalemic hypertension caused by gene mutation of WNK4. Am J. Physiol Renal Physiol 2007; 292: F545-F554
218. Ko B., Hoover R.S. Molecular physiology of the thiazidesensitive sodium-chloride cotransporter. Curr Opin Nephrol Hypertens 2009; 18 (5): 421-427
219. Yang C.L., Zhu X., Ellison D.H. The thiazide-sensitive Na-Cl cotransporter is regulated by a WNK kinase signaling complex. J. Clin Invest 2007; 117 (11): 3403-3411
220. Adams J., Song C., Kantorovich V. Rapid recovery of bone mass in hypercalciuric, osteoporotic men treated with hydrochlorothiazide. Ann Intern Med 1999; 130: 658-660
221. Shin J.I., Park S.J., Kim J.H. Low-dose or high-dose hydrochlorothiazide in idiopathic hypercalciuria among children? Iran J. Kidney Dis 2012; 6 (1): 77
222. Choi J.N., Lee J.S., Shin J.I. Low-dose thiazide diuretics in children with idiopathic renal hypercalciuria. Acta Paediatr 2011; 100 (8): e71-e74
223. Reusz G. Idiopathic hypercalciuria in childhood. Orv Hetil 1998; 139 (49): 2957-2962
224. Naseri M., Alamdaran S.A. Metabolic factors associated with urinary calculi in children. Iran J. Kidney Dis 2010; 4 (1): 32-38
225. Naseri M. Author’s reply. Iran J. Kidney Dis 2012; 6 (1): 77-78
226. Huen S.C., Goldfarb D.S. Adverse metabolic side effects of thiazides: implications for patients with calcium nephrolithiasis. J. Urol 2007; 177: 1238-1243
227. Жариков А.Ю., Зверев Я.Ф., Лампатов В.В. и др. Опыт применения натрия пирофосфата при оксалатном нефролитиазе в эксперименте. Бюллетень сибирской медицины 2011; (1): 32-37
228. Bone H.G., Zerwekh J.E., Britton F. et al. Treatment of calcium urolithiasis with diphosphonate: efficacy and hazards. J. Urol 1979; 121: 568-571
229. Ruml L.A., Dubois S.K., Roberts M.L. et al. Prevention of hypercalciuria and stone-forming propensity during prolonged bed rest by alendronate. J. Bone Miner Res 1995; 10: 655-662
230. Heliberg I.P., Martini L.A., Teixeria S.H. et al. Effect of etidronate treatment on bone mass of male nephrolithiasis and osteopenia. Nephron 1998; 79; 430-437
231. Arrabal-Martin M., Di'az de la Guardia F.V., Jiménez Pacheco A. et al. The treatment of renal lithiasis with bisphosphonates. Arch Esp Urol 2007; 60 (7): 745-754
232. Bushinsky D.A., Neumann K.J., Asplin J. et al. Alendronate decreases urine calcium and supersaturation in genetic hypercalciuric rats. Kidney Int 1999; 55: 234-243
233. Giusti A., Barone A., Pioli G. et al. Alendronate and indapamide alone or in combination in the management of hypercalciuria associated with osteoporosis: a randomized controlled trial of two drugs and three treatments. Nephrol Dial Transplant 2009; 24 (5): 1472-1477
234. Arrabal-Polo M.A., Arias-Santiago S., de Haro-Muñoz T. et al. Effects of aminobisphosphonates and thiazides in patients with osteopenia/osteoporosis, hypercalciuria and recurring renal calcium lithiasis. Urology 2013; 81 (4): 731-737
235. Freundlich M., Alon U.S. Bisphosphonates in children with hypercalciuria and reduced bone mineral density. Pediatr Nephrol 2008; 23: 2215-2220
236. Pazianas M., Miller P., Blumentals W. et al. A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics. Clin Ther 2007; 29: 1548-1558
237. Ruggiero S., Drew S. Osteonecrosis of the jaws and bisphosphonate therapy. J. Dent Res 2007; 86: 1013-1021
238. Buck A.C., Davies R.L., Harrison T. The protective role of eicosapentaenoic acid (EPA) in the pathogenesis of nephrolithiasis. J. Urol 1991; 146: 188-194
239. Kromhout D., Bosschietter E.B., de Lezenne Coulander C. The inverse relation between fish consumption and 20-year mortality from coronary heart disease. N Engl J. Med 1985; 312: 1205-1209
240. Rothwell P.J., Green R., Blacklock N.J. et al. Does fish oil benefit stone formers? J. Urol 1993; 150: 1391-1394
241. Dyerberg J., Bang H.O., Hjorne N. Fatty acid composition of the plasma lipids in Greenland Eskimos. Am J. Clin Nutr 1975; 28: 958-966
242. Bang H.O., Dyerberg J., Hjoorne N. The composition of food consumed by Greenland Eskimos. Acta Med Scand 1976; 200: 69-73
243. Kromann N., Green A. Epidemiological studies in the Upernavik district, Greenland. Incidence of some chronic diseases 1950-1974. Acta Med Scand 1980; 208: 401-406
244. Gibson R.A., Sinclair A.J. Are Eskimos obligated carnivores? Lancet 1981; 1 (8229): 1100
245. Baggio B., Gambaro G., Zambon S. et al. Anomalous phospholipid n-6 polyunsaturated fatty acid composition in idiopathic calcium nephrolithiasis. J. Am Soc Nephrol 1996; 7: 613-620
246. Baggio D., Budakovic A., Nassuato A. et al. Plasma phospholipid arachidonic acid content and calcium metabolism in idiopathic calcium nephrolithiasis. Kidney Int 2000; 58 (3): 1278-1284
247. Gambaro G., Checchetto S., Bacelle L. et al. Dietary polyunsaturated fatty acids and idiopathic calcium nephrolithiasis. In: Jungers P., Daudon M., eds. Proceedings of the 7th European Symposium on Urolithiasis, Elsevier, Paris, 1997; 88
248. Ito H., Kotake T., Nomura K. Effect of ethyl icosapentate on urinary calcium excretion in calcium oxalate stone formers. Urol Int 1995; 54: 208-213
249. Konya E., Tsuji H., Umekawa T. et al. Effect of ethyl icosapentate on urinary calcium and oxalate excretion. Int J. Urol 2000; 7: 361-365
250. Yasui T., Tanaka H., Fujita K. et al. Effects of eicosapentaenoic acid on urinary calcium excretion in calcium stone formers. Eur Urol 2001; 39: 580-585
251. Ortiz-Alvarado O., Miyaoka R., Kriedberg C. et al. Omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid in the management of hypercalciuric stone formers. Urology 2012; 79 (2): 282-286
252. Buck A.C., Lote C.J., Sampson W.F. The influence of renal prostaglandins on urinary calcium excretion in idiopathic urolithiasis. J. Urol 1983; 129 (2): 421-426
253. Friedlander G., Amiel C. Decreased calcium and magnesium urinary excretion during prostaglandin synthesis inhibition in the rat. Prostaglandins 1985; 29 (1): 123-132
254. Gomaa A.A., Hassan H.A., Ghaneimah S.A. Effect of aspirin and indomethacin on the serum and urinary calcium, magnesium and phosphate. Pharmacological Research 1990; 22 (1): 59-70
255. Жариков А.Ю., Зверев Я.Ф., Брюханов В.М. и др. Антилитогенное действие мелоксикама при экспериментальном нефролитиазе. 2012 Экспериментальная и клиническая фармакология 2012; 75 (3): 14-17
Рецензия
Для цитирования:
Михеева Н.М., Зверев Я.Ф., Выходцева Г.И. Идиопатическая гиперкальциурия у детей. Нефрология. 2014;18(1):33-52.
For citation:
Mikheeva N.M., Zverev Ya.F., Vykhodceva G.I. Idiopathic hypercalciuria in children. Nephrology (Saint-Petersburg). 2014;18(1):33-52. (In Russ.)
Просмотров:
1651
Послать статью по эл. почте 